Cancer and Melatonin: Updates on Current Findings
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 30 September 2026 | Viewed by 1399
Special Issue Editor
Interests: antioxidants; sex differences; skin; melatonin; oxidative stress and cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a disease that is continuously rising worldwide, thus constituting an important global health problem. Cancer patients are mainly treated with conventional protocols, including chemotherapy, radiotherapy, and surgery. However, these treatments are often associated with toxicity, incomplete tumor eradication, and various side effects. Due to these drawbacks, complementary and alternative therapies are attracting increasing interest in scientific research. Among these, melatonin emerged as a particularly promising strategy to enhance the efficacy of conventional anticancer therapies. Melatonin is an indoleamine secreted by the pineal gland and other organs. It is traditionally recognized for its role in regulating circadian rhythms and sleep; however, it has emerged as a multifunctional and pleiotropic molecule with antioxidant, anti-inflammatory, and immunomodulatory properties. To date, its antitumor activity is primarily preclinical and remains to be confirmed and amplified.
This Special Issue aims to provide a comprehensive overview of the current knowledge about the mechanism of action(s) of melatonin against cancer diseases and the impact of this complementary strategy. We welcome the submission of different article types to this collection, especially reviews and original research papers.
Prof. Dr. Rita Rezzani
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- melatonin
- oxidative stress
- inflammation
- antioxidant defense
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
